Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks beta-arrestin recruitment and calcium flux with IC50s [1][2].
Molecular Weight:
1978.16
Purity:
99.78
Formula:
C86H119F3N24O23S2
Target:
Arrestin,CXCR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
